In financial accounting, a balance sheet is a summary of the financial balances of an individual or organization, whether it be a sole proprietorship, a business partnership, a corporation, private limited company or other organization such as government or not-for-profit entity.

Antisense Therapeutics Limited Balance Sheet Statement - Assets

As of 30 Jun 2022, The total current assets of Antisense Therapeutics Limited (ASX:ANP) was around $22,219,959 which consisted of $19,233,183 of Cash, no Inventory and $1,840,976 of Net receivables. Current assets represent all the assets of a company that are expected to be conveniently sold, consumed, used, or exhausted through standard business operations within one year.

All amounts in AUD

Cash
$19.23M
Current assets
$22.22M
Total assets
$22.44M

The latest balance sheet of Antisense Therapeutics Limited also showed $216,699 of Property Plant Equipment and no Good will. Also there were no Intangible assets and no Other assets. The total assets including current and Intangibles/Deferred Long Term Asset Charges were $22,436,658.

Antisense Therapeutics Limited Balance Sheet Statement - Liabilities

ANP's latest annual results shows the balance sheet has $331,404 of Accounts Payable. Also there were no Short/Long term debt, no Long term debt, $4,577 of Other Current liabilities and $1,160,772 of Total Current Liabilities. Current liabilities are a company's short-term financial obligations that are due within one year or within a normal operating cycle.

Account payable
$331.4k
Current liabilities
$1.16M
Total liabilities
$1.3M

As per the 30 Jun 2022's annual report of Antisense Therapeutics Limited, the total liabilities were $1,295,219.

ANP Balance Sheet Statement - Stock Holder Equity

Stockholders' equity, also referred to as shareholders' equity, is the remaining amount of assets available to shareholders after all liabilities have been paid. It is calculated either as a firm's total assets less its total liabilities or alternatively as the sum of share capital and retained earnings less treasury shares. Stockholders' equity might include common stock, paid-in capital, retained earnings and treasury stock.

The latest Balance sheet of Antisense Therapeutics Limited showed the total stock holder equity was $21,141,439 which consisted of $98,134,995 of Common stocks, $-80,909,390 of Retained earnings and $3,915,834 of Other stock holder equity.

ANP Balance Sheet Statement History

Following table shows the history of balance sheet for Antisense Therapeutics Limited (ANP).

30 Jun 202230 Jun 202130 Jun 202030 Jun 2019
Cash19.23M6.02M4.06M2.9M
Net Receivables1.84M601.25k689.32k606.47k
Inventory----
Total Current Assets22.22M6.7M5.21M3.7M
Property Plant Equipment216.7k302k138.12k2.3k
Good Will----
Intangible Assets----
Other Assets----
Deferred Long Term Asset Charges----
Total Assets22.44M7M5.35M3.7M
Accounts Payable331.4k157.07k107.87k227.13k
Short/Long Term Debt----
Other Current Liabilities4.58k4.58k4.58k4.58k
Long Term Debt----
Other Liabilities1.14k117-9.08k
Total Current Liabilities1.16M1.05M798.54k879.75k
Total Liabilities1.3M1.27M821.23k888.84k
Common Stock98.13M77.03M69.15M63.94M
Retained Earnings-80.91M-75.1M-67.04M-61.13M
Treasury Stock3.92M3.79M2.42M-
Other Stockholder Equity3.92M3.79M2.42M-
Total Stockholder Equity21.14M5.73M4.53M2.81M
Net Tangible Assets21.14M5.73M4.53M2.81M

Antisense Therapeutics Limited (ASX:ANP) Balance Sheet Statement FAQ

1. How much Cash Antisense Therapeutics Limited has on their balance sheet?

As of 30 Jun 2022, Antisense Therapeutics Limited (ASX:ANP) has $19,233,183 of Cash.

2. What's the long term debt of Antisense Therapeutics Limited?

As per the latest Balance sheet of Antisense Therapeutics Limited (ASX:ANP), it has no Long term debt.

3. How much share holder equity does Antisense Therapeutics Limited has?

The Antisense Therapeutics Limited (ASX:ANP)'s balance sheet shows that it has $21,141,439 of Total stock holder equity.